Intet billede af Carla Maria Lourenco Alves

Carla Maria Lourenco Alves

Hvis du har foretaget ændringer i Pure, vil de snart blive vist her.

Publikationer

  • 4 Poster
  • 3 Tidsskriftartikel
  • 1 Ph.d.-afhandling
Filtrer
Poster
2016

CDK6 as a predictive marker of response to fulvestrant treatment and a potential indicator of benefit from CDK4/6 inhibitor therapy in estrogen receptor-positive metastatic breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. E. & Ditzel, H., 9. jul. 2016.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

2015

High expression of CDK6 confers resistance to fulvestrant in breast cancer cells and is a potential predictor of fulvestrant treatment failure in estrogen receptor-positive breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. E. & Ditzel, H., 7. feb. 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

Fil
96 Downloads (Pure)

High expression of CDK6 protects breast cancer cells from fulvestrant-mediated apoptosis and is a predictor of resistance to fulvestrant treatment in estrogen receptor-positive metastatic breast cancer

Alves, C. M. L., Elias, D., Lyng, M. B., Bak, M., Lykkesfeldt, A. & Ditzel, H., 2015.

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review